KCM
ZVRA icon

Kingdon Capital Management’s Zevra Therapeutics ZVRA Stock Holding History

Kingdon Capital Management’s Portfolio ZVRA Stock Details ZVRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$7.22M Buy
775,000
+189,931
+32% +$1.71M 1.21% 43
2025
Q4 		$5.24M Sell
585,069
-64,931
-10% -$614K 0.8% 55
2025
Q3 		$6.18M Buy
650,000
+200,000
+44% +$2.01M 0.97% 56
2025
Q2 		$3.96M Buy
+450,000
New +$3.65M 0.77% 56
2016
Q4 		– Sell
-16,248
Closed -$1.17M – 178
2016
Q3 		$1.17M Hold
16,248
– – 0.08% 111
2016
Q2 		$1.03M Buy
16,248
+1,359
+9% +$224K 0.08% 97
2016
Q1 		$3.45M Buy
14,889
+2,177
+17% +$527K 0.27% 86
2015
Q4 		$4.04M Sell
12,712
-4,188
-25% -$1.14M 0.3% 85
2015
Q3 		$5.24M Buy
16,900
+2,837
+20% +$869K 0.43% 81
2015
Q2 		$4.13M Buy
+14,063
New +$3.07M 0.24% 104

Other funds holding ZVRA

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $488M AUM 327.32% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return